BFM
KRRO icon

Boothbay Fund Management’s Korro Bio KRRO Stock Holding History

Boothbay Fund Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$310K – 1669
2020
Q4 		$310K Buy
+2
New +$2.64K 0.01% 936

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Boothbay Fund Management's KRRO Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Korro Bio (KRRO) in Q1 2026: 42,000 shares worth $475K. The stake represents 0.01% of the portfolio and ranks #1382 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in KRRO as recently as Q4 2020.

Boothbay Fund Management first reported a position in KRRO in Q4 2020 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Boothbay Fund Management held 42,000 shares of Korro Bio worth $475K as of Q1 2026.
  • Korro Bio was a new Boothbay Fund Management position in Q1 2026.
  • Korro Bio made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1382 holding.
  • Boothbay Fund Management first reported a position in Korro Bio in Q4 2020 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.